# A Multi-center 12-week Study of HMS5552 in T2DM

> **NCT02561338** · PHASE2 · COMPLETED · sponsor: **Hua Medicine Limited** · enrollment: 258 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** HMS5552
- **DRUG:** HMS5552
- **DRUG:** HMS5552
- **DRUG:** HMS5552
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02561338
- **Lead sponsor:** Hua Medicine Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561338, "A Multi-center 12-week Study of HMS5552 in T2DM". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02561338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*